Strengthening China’s National Essential Public Health Services Package for hypertension and diabetes care
Protocol for an interrupted time series study with mixed-methods process evaluation and health economic evaluation
Bibliographic Data
The study has been registered on Chinese Clinical Trial Registry at https://www.chictr.org.cn/ (Registration number ChiCTR2400082036, on March 19th 2024)
Biostatistics · China · Economic growth · Environmental health · Health care · Psychological intervention · Public health · Health Systems, Economic Evaluations, Quality of Life · Healthcare Systems and Reforms · Medicine · Nursing · Primary Care and Health Outcomes · Health Policy
Prevalence, awareness, treatment, and control of hypertension in China
Conducting Interrupted Time-series Analysis for Single- and Multiple-group Comparisons
Understanding and applying the RE-AIM framework
RE-AIM Planning and Evaluation Framework
Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association
Quality of primary health care in China
Better reporting of interventions
Establishing cost-effectiveness threshold in China
| Unique citing works | 2 |
|---|---|
| Citations per year | 2 |
| Citation span | 2026 - 2026 (1) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 2 |